Go to Wolters Kluwer VitalLaw.comGo to Wolters Kluwer VitalLaw.com
VitalLaw®
  • Find answers to your questions
  • Log in to access your subscriptions
In depth. On point.
In depth. On point.
  • Home
  • Legal Directory
  • Home
  • Legal Directory
In depth. On point.
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations
    • TOP STORY: FTC conditionally approves combination of glass container makers
    • ADVERTISING—D. Ariz.: FTC Act claims transferred to Utah court
    • ANTITRUST NEWS: Agencies attempt to encourage cyber threat information sharing with policy statement
    • ANTITRUST NEWS: New Zealand Commerce Commission announces imposition of penalties on final air freight cartel participant
    • ANTITRUST NEWS: Senate Judiciary members probe effects of Comcast-TWC deal
    • ANTITRUST NEWS: Two more auto parts executives sentenced in price fixing investigation
    • ANTITRUST—J.P.M.L.: Conspiracy to suppress generic drug competition suits centralized in Connecticut; California
    • ANTITRUST—Kan. App. Ct.: Decertification of class in leather goods price fixing conspiracy remanded
    • BLOG TRACKER—Noteworthy blog posts and other commentary
    • PRIVACY NEWS: Facebook, WhatsApp notified of potential for FTC action concerning privacy policies in light of a proposed acquisition
    • STATE UNFAIR TRADE PRACTICES—D.D.C.: Consumer group’s suit challenging bread maker’s marketing practices remanded
    • STATE UNFAIR TRADE PRACTICES—N.D. Cal.: Primary jurisdiction lies with FDA in evaporated cane juice dispute
  • Articles
  • Articles
  • Law Firms
  • Law Firms
  • Organizations
  • Organizations

    Antitrust Law Daily Wrap Up, ANTITRUST NEWS: Two more auto parts executives sentenced in price fixing investigation, (Apr 10, 2014)

    Law Firms Mentioned:Cozen & O’Connor | Sullivan & Cromwell
    Organizations Mentioned:Cozen & O'Connor, PC | Nissan Motor Co., Ltd. | Sullivan & Cromwell, LLP | Takata Corp. | U.S. Department of Justice

    By Jeffrey May, J.D.

    Two executives from Japan-based seatbelt manufacturer Takata Corp. were sentenced by the federal district court in Detroit this week after pleading to participating in a conspiracy to fix prices for seatbelts. Yasuhiko Ueno and Yoshinobu Fujino will ...

    By Jeffrey May, J.D.

    Two executives from Japan-based seatbelt manufacturer Takata Corp. were sentenced by the federal district court in Detroit this week after pleading to participating in a conspiracy to fix prices for seatbelts. Yasuhiko Ueno and Yoshinobu Fujino will serve prison time and each pay a $20,000 fine (U.S. v. Ueno, Criminal No. 2:13-CR-20870-SFC-RSW; U.S. v. Fujino, Criminal No. 5:13-CR-20869-JCO-RSW).

    In November 2013, one-count felony charges were filed against Ueno and Fujino, as well as a third Takata executive—Saburo Imamiya—for conspiring to fix prices and rig bids for seatbelts sold to Toyota Motor Corp., Honda Motor Co. Ltd., Nissan Motor Co. Ltd., Mazda Motor Corp., and Fuji Heavy Industries Inc., more commonly known as Subaru.

    Pursuant to the plea agreements, Ueno was sentenced to serve 19 months in prison and to pay a $20,000 fine, and Fujino was sentenced to serve 14 months in prison and to pay a $20,000 fine.

    Imamiya also agreed to plead guilty, and last month was sentenced to serve 16 months in prison and to pay a $20,000 fine.

    Takata was fined $71.3 million in December 2013 for its role in the conspiracy. Gary Walker, a U.S. citizen and a former executive of Takata’s U.S. subsidiary was charged in September 2013 and agreed to plead guilty to the charge and to serve 14 months in prison and pay a $20,000 fine.

    Attorneys: Kathryn Hellings for U.S. Department of Justice Antitrust Division. L. Barrett Boss (Cozen & O’Connor) for Yoshinobu Fujino. Steven Peikin (Sullivan & Cromwell) for Yasuhiko Ueno.

    Companies: Takata Corp.

    News: Antitrust AntitrustDivisionNews

    © 2026 CCH Incorporated and its affiliates and licensors. All rights reserved.

    • Manage Cookie Preferences
    • Privacy Statement
    • Terms of Use